Late syphilis, other and unspecified
ICD-10 A52.8 is a billable code used to indicate a diagnosis of late syphilis, other and unspecified.
Late syphilis is a stage of syphilis that occurs after the primary and secondary stages, typically occurring years after the initial infection if left untreated. It is characterized by the presence of gummas, cardiovascular syphilis, and neurosyphilis. Gummas are soft, tumor-like growths that can occur in various tissues, including skin, bones, and organs. Cardiovascular syphilis can lead to aortitis and other cardiovascular complications, while neurosyphilis can manifest as meningitis, tabes dorsalis, or general paresis. The condition is primarily transmitted through sexual contact, but can also be passed from mother to child during pregnancy. Diagnosis is made through serological testing, including non-treponemal tests (e.g., RPR, VDRL) and treponemal tests (e.g., FTA-ABS). Treatment typically involves the administration of benzathine penicillin G, with the dosage and duration depending on the stage and severity of the disease. Late syphilis can have significant health implications if not treated, including potential long-term damage to the cardiovascular and nervous systems.
Detailed clinical notes on symptoms, serological test results, and treatment plans.
Patients presenting with neurological symptoms or gummas.
Consideration of co-infections and comprehensive treatment plans.
Documentation of maternal and fetal health, including serological testing during pregnancy.
Pregnant women with a history of syphilis requiring monitoring.
Importance of screening and treatment to prevent congenital syphilis.
Used to confirm diagnosis of syphilis in patients presenting with symptoms.
Document the reason for testing and results.
Infectious disease specialists may require additional tests for comprehensive evaluation.
Common symptoms include gummas, neurological issues, and cardiovascular problems. Patients may also be asymptomatic.
Treatment typically involves benzathine penicillin G, with the dosage and duration depending on the severity of the disease.
